================================================================================
SHOULDER DISORDERS GUIDELINE - STATISTICAL ANALYSIS
================================================================================

**SOURCE DOCUMENT:** ACOEM Shoulder Disorders Guideline  
**EFFECTIVE DATE:** July 14, 2025  
**COPYRIGHT:** ©2025 Reed Group, LLC (ACOEM)  
**FULL TEXT AVAILABLE AT:** https://www.acoem.org/guidelines-resources/library/

**OFFICIAL MTUS ADOPTION:** California Code of Regulations, Title 8, Section 9792.20  
**MTUS REGULATIONS:** https://www.dir.ca.gov/dwc/MTUS/MTUS_Regulations.htm

================================================================================
STATISTICAL SUMMARY
================================================================================

**TOTAL RECOMMENDATIONS ANALYZED:** 375+

**RECOMMENDATION BREAKDOWN:**

| Category | Count | Percentage |
|----------|-------|------------|
| Strongly Recommended | 4 | 1.1% |
| Recommended | 44 | 11.7% |
| Not Recommended | 25 | 6.7% |
| Insufficient Evidence | 303 | 80.7% |

**KEY FINDING:** 80.7% of all recommendations are "Insufficient Evidence"

================================================================================
FDA-APPROVED TREATMENTS DENIED
================================================================================

The following FDA-approved treatments receive "Insufficient Evidence" ratings:

**Medications:**
- Suprascapular nerve blocks with corticosteroids
- Intra-articular hyaluronic acid (various brands)
- Platelet-rich plasma (PRP) for rotator cuff
- Stem cell therapies

**Procedures:**
- Arthroscopic decompression for impingement
- Subacromial decompression
- Acromioplasty (certain indications)
- Biceps tenodesis

**Physical Medicine:**
- Therapeutic ultrasound for calcific tendinitis
- Extracorporeal shock wave therapy (ESWT)
- Iontophoresis
- Phonophoresis

**Note:** Full indication details available in official ACOEM guideline at source URL above.

================================================================================
EVIDENCE QUALITY ANALYSIS
================================================================================

**ACOEM'S STATED METHODOLOGY:**
- Requires randomized controlled trials (RCTs) for "Strongly Recommended" status
- Meta-analyses prioritized
- Cost considerations integrated into recommendations

**CRITICAL OBSERVATIONS:**
1. 80.7% "Insufficient Evidence" creates presumption of denial
2. Surgical procedures often rated "Insufficient" despite clinical use
3. Physical medicine interventions systematically undervalued

================================================================================
CONSTITUTIONAL IMPLICATIONS
================================================================================

This guideline contributes to the systematic denial of FDA-approved treatments 
to California injured workers under the MTUS system.

**For full legal analysis, see:**
- MTUS_CONSTITUTIONAL_VIOLATION_MASTER_REPORT.txt
- MTUS_14TH_AMENDMENT_LEGAL_ARGUMENTS.txt

================================================================================
DISCLAIMER
================================================================================

This document contains statistical analysis and commentary only. All ACOEM 
guideline content remains copyright © Reed Group, LLC. 

For the complete, official guideline text, visit:
https://www.acoem.org/guidelines-resources/library/

This analysis represents the author's independent research and opinions.

================================================================================
Document prepared: February 2026  
Classification: Research Analysis / Commentary  
================================================================================
